Primarily used in the field of medicinal chemistry, this compound is investigated for its potential as an antidiabetic agent. It belongs to the class of sulfonylureas, which are known to stimulate insulin secretion from pancreatic beta cells, making it a candidate for managing type 2 diabetes. Researchers study its efficacy in lowering blood glucose levels and its pharmacokinetic properties to determine its suitability as an oral hypoglycemic drug. Additionally, its structural features are analyzed for optimizing therapeutic effects and minimizing side effects, such as hypoglycemia or weight gain. Beyond diabetes research, it may also be explored for its role in other metabolic disorders or as a tool in biochemical studies to understand insulin regulation pathways.